Cargando…

Investigation of Statin Medication Use in Elderly Patients with Cardiovascular Disease on Regular Physical Examination and the Relationship with Glucolipid Metabolism and Adverse Cardiovascular Prognosis

Our purpose of this study was to investigate the use of statins in elderly patients with cardiovascular diseases during regular physical examination and to analyze the relationship between statins and glucose and lipid metabolism and adverse cardiovascular prognosis. From January 2019 to December 20...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Chang, Ma, Rui, Gao, Daifeng, Hu, Bin, Yin, Xiaolei, Liu, Zhipeng, Lin, Hu, Zhang, Zhenhua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9225898/ https://www.ncbi.nlm.nih.gov/pubmed/35756493 http://dx.doi.org/10.1155/2022/8714392

Ejemplares similares

Statins for primary cardiovascular prevention in the elderly
por: Pedro-Botet, Juan, et al.
Publicado: (2015)

Activating transcription factor 3, glucolipid metabolism, and metabolic diseases
por: Hu, Shuwei, et al.
Publicado: (2022)

Microecological preparation combined with an modified low-carbon diet improves glucolipid metabolism and cardiovascular complication in obese patients
por: Liu, Jianguo, et al.
Publicado: (2021)

The role of FOXA family transcription factors in glucolipid metabolism and NAFLD
por: Yu, Chuchu, et al.
Publicado: (2023)

Role of Statin Therapy in Primary Prevention of Cardiovascular Disease in Elderly Patients
por: Strandberg, Timo E.
Publicado: (2019)

Efficacy of statin treatment based on cardiovascular outcomes in elderly patients: a standard meta-analysis and Bayesian network analysis
por: Zhai, Chuannan, et al.
Publicado: (2020)

Statins; the panacea of cardiovascular disease
por: de Waard, G. A., et al.
Publicado: (2017)

Clinical utility of rosuvastatin and other statins for cardiovascular risk reduction among the elderly
por: Long, Sydney B, et al.
Publicado: (2011)

Association between regular exercise and the risk of major adverse cardiovascular events in patients with pacemaker
por: Lee, S R, et al.
Publicado: (2023)

Effects of Cyclocarya paliurus Aqueous and Ethanol Extracts on Glucolipid Metabolism and the Underlying Mechanisms: A Meta-Analysis and Systematic Review
por: Liu, Wei, et al.
Publicado: (2020)

Mechanisms for Improving Hepatic Glucolipid Metabolism by Cinnamic Acid and Cinnamic Aldehyde: An Insight Provided by Multi-Omics
por: Wu, You, et al.
Publicado: (2022)

Non-cardiovascular effects associated with statins
por: Desai, Chintan S, et al.
Publicado: (2014)

Effect of “maccog” TCM tea on improving glucolipid metabolism and gut microbiota in patients with type 2 diabetes in community
por: Hu, Biyue, et al.
Publicado: (2023)

SIRT1 promotes glucolipid metabolic conversion to facilitate tumor development in colorectal carcinoma
por: Wei, Zhihao, et al.
Publicado: (2023)

Early and Regular Bronchoscopy Examination on Effect of Diagnosis and Prognosis for Patients With Tracheobronchial Tuberculosis
por: Hu, Tingting, et al.
Publicado: (2022)

Epigallocatechin-3-gallate ameliorates glucolipid metabolism and oxidative stress in type 2 diabetic rats
por: Li, Wenru, et al.
Publicado: (2020)

The efficacy and safety of statin in combination with ezetimibe compared with double-dose statin in patients with high cardiovascular risk: A meta-analysis
por: Zhu, Yunyun, et al.
Publicado: (2020)

Explorative research on glucolipid metabolism and levels of adipokines in pseudohypoparathyroidism type 1 patients
por: Yang, Yi, et al.
Publicado: (2023)

Impact of Plasma Exposure of Statins and Their Metabolites With Major Adverse Cardiovascular Events in Chinese Patients With Coronary Artery Disease
por: Zhou, Xiao-hong, et al.
Publicado: (2020)

Cardiovascular Risk and Statin Therapy Considerations in Women
por: Gheorghe, Gina, et al.
Publicado: (2020)

Rebalancing glucolipid metabolism and gut microbiome dysbiosis by nitrate-dependent alleviation of high-fat diet-induced obesity
por: Ma, Linsha, et al.
Publicado: (2020)

Effects of a Secondary Prevention Combination Therapy with beta-Blocker and Statin on Major Adverse Cardiovascular Events in Acute Coronary Syndrome Patients
por: Zhu, Ling, et al.
Publicado: (2020)

Identification of Nonylphenol and Glucolipid Metabolism-Related Proteins in the Serum of Type 2 Diabetes Patients
por: YA, Luo, et al.
Publicado: (2019)

Wildfire smoke exposure and cardiovascular disease—should statins be recommended to prevent cardiovascular events?
por: Vuorio, Alpo, et al.
Publicado: (2023)

Effects of Poria cocos extract and protein powder mixture on glucolipid metabolism and rhythm changes in obese mice
por: Xie, Qiaoling, et al.
Publicado: (2023)

The Effect of Probiotic Supplementation on Glucolipid Metabolism in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis
por: Xiao, Rui, et al.
Publicado: (2023)

Liraglutide protects pancreatic β-cells against free fatty acids in vitro and affects glucolipid metabolism in apolipoprotein E(−/−) mice by activating autophagy
por: WANG, JIA, et al.
Publicado: (2015)

Clinical efficacy and safety of statins in managing cardiovascular risk
por: Kapur, Navin K, et al.
Publicado: (2008)

Use of Aspirin and Statin as primary prevention for cardiovascular diseases
por: Alkhail, Bahaa Aba, et al.
Publicado: (2016)

Statins alone or polypill for primary prevention of cardiovascular diseases
por: Hasani-Ranjbar, Shirin, et al.
Publicado: (2016)

Atherogenic Lipoproteins for the Statin Residual Cardiovascular Disease Risk
por: Yanai, Hidekatsu, et al.
Publicado: (2022)

Effects of the glucolipid synthase inhibitor, P4, on functional and phenotypic parameters of murine myeloma cells
por: Manning, L S, et al.
Publicado: (1999)

Androgen-induced gut dysbiosis disrupts glucolipid metabolism and endocrinal functions in polycystic ovary syndrome
por: Han, Qixin, et al.
Publicado: (2021)

Characterization of the chicken melanocortin 5 receptor and its potential role in regulating hepatic glucolipid metabolism
por: Zhang, Xiao, et al.
Publicado: (2022)

Characteristics of glucolipid metabolism and complications in novel cluster-based diabetes subgroups: a retrospective study
por: Li, Xinrong, et al.
Publicado: (2023)

Long-term cardiovascular adverse events in very elderly COVID-19 patients
por: Karadavut, Serhat, et al.
Publicado: (2022)

DIA-PRM Proteomic Analysis of Phlegm-Dampness Constitution with Glucolipid Metabolic Disorders by the Intervention of Hua Tan Qu Shi Recipe
por: Li, Yuanyuan, et al.
Publicado: (2022)

Combining Potent Statin Therapy with Other Drugs to Optimize Simultaneous Cardiovascular and Metabolic Benefits while Minimizing Adverse Events
por: Koh, Kwang Kon, et al.
Publicado: (2017)

Effect of Statins on Major Adverse Cardiovascular Events in Patients with Coronary Artery Spasm: A Meta-Analysis of the Asia Region
por: Zhao, Tian-Jun, et al.
Publicado: (2023)

Impact of Chinese Herbal Medicine on Glucolipid Metabolic Outcomes in Women with Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis
por: Li, Jie, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_hn5a585js94t6sb3i899fp7t3m